Spruce Biosciences (SPRB)
(Delayed Data from NSDQ)
$0.44 USD
-0.01 (-2.59%)
Updated Sep 20, 2024 04:00 PM ET
After-Market: $0.44 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
F Value B Growth A Momentum C VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 11/11/24 |
---|---|
Current Quarter | -0.27 |
EPS Last Quarter | -0.22 |
Last EPS Surprise | 33.33% |
ABR | 2.43 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -1.12 |
Next Year | -1.08 |
EPS (TTM) | -1.03 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 1.80M | 1.55M | 5.80M | 5.10M |
# of Estimates | 2 | 2 | 3 | 2 |
High Estimate | 2.00M | 1.60M | 7.00M | 5.20M |
Low Estimate | 1.60M | 1.50M | 3.60M | 5.00M |
Year ago Sales | 3.07M | 2.89M | 10.09M | 5.80M |
Year over Year Growth Est. | -41.37% | -46.37% | -42.51% | -12.07% |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.27 | -0.28 | -1.12 | -1.08 |
# of Estimates | 3 | 3 | 4 | 4 |
Most Recent Consensus | -0.24 | -0.27 | -1.02 | -1.02 |
High Estimate | -0.24 | -0.27 | -1.02 | -0.84 |
Low Estimate | -0.29 | -0.29 | -1.23 | -1.42 |
Year ago EPS | -0.30 | -0.23 | -1.24 | -1.12 |
Year over Year Growth Est. | 10.00% | -21.74% | 9.68% | 4.02% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 2 | 2 | 2 | 1 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 1 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.27 | -0.28 | -1.12 | -1.08 |
7 Days Ago | -0.27 | -0.28 | -1.12 | -1.08 |
30 Days Ago | -0.27 | -0.28 | -1.12 | -1.08 |
60 Days Ago | -0.32 | -0.31 | -1.24 | -1.03 |
90 Days Ago | -0.32 | -0.31 | -1.24 | -1.03 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.27 | -0.28 | -1.12 | -1.08 |
Zacks Consensus Estimate | -0.27 | -0.28 | -1.12 | -1.08 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.22 | -0.28 | -0.23 | -0.30 | NA |
Estimate | -0.33 | -0.32 | -0.41 | -0.34 | NA |
Difference | 0.11 | 0.04 | 0.18 | 0.04 | 0.09 |
Surprise | 33.33% | 12.50% | 43.90% | 11.76% | 25.37% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more